Mark Bures

Title: Mark Bures: Innovator in Cancer Treatment

Introduction

Mark Bures is a notable inventor based in Zionsville, Indiana, who has made significant contributions to the field of cancer treatment through his innovative research. With a total of two patents to his name, Bures is dedicated to developing compounds that target specific enzymes involved in cancer progression.

Latest Patents

Bures' latest patents focus on inhibitors of the MYST family of lysine acetyltransferases. These compounds, described by the formula (I), are designed to inhibit KAT6A and KAT6B, enzymes that are often mutated or overexpressed in various cancers. The patents detail methods for the preparation of these compounds and their potential use in pharmaceutical compositions aimed at treating hyperproliferative diseases, including cancer. The compounds may also be effective when used in combination with other anti-cancer agents.

Career Highlights

Mark Bures is currently associated with Isosterix, Inc., where he continues to advance his research in the field of cancer therapeutics. His work is characterized by a commitment to finding innovative solutions for complex medical challenges.

Collaborations

Bures collaborates with Roopa Rai, contributing to a dynamic research environment focused on the development of effective cancer treatments.

Conclusion

Mark Bures exemplifies the spirit of innovation in the medical field, particularly in cancer research. His patents and ongoing work at Isosterix, Inc. highlight his dedication to improving treatment options for patients facing hyperproliferative diseases.